Alpha Mark Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Alpha Mark Advisors, LLC

$290 Million
Q3 2024

A detailed history of Alpha Mark Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 4,652 shares of VRTX stock, worth $2.34 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

4,652

Previous 4,958 6.17%

Holding current value

$2.34 Million

Previous $2.32 Million 6.88%

% of portfolio

0.75%

Previous 0.81%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$460.0 - $505.78 $140,760 - $154,768	-306 Reduced 6.17%	4,652 $2.16 Million
Q2 2024 Jul 17, 2024	SELL	$392.81 - $485.53 $90,739 - $112,157	-231 Reduced 4.45%	4,958 $2.32 Million
Q1 2024 Apr 18, 2024	SELL	$407.69 - $446.08 $187,945 - $205,642	-461 Reduced 8.16%	5,189 $2.17 Million
Q4 2023 Jan 19, 2024	SELL	$343.0 - $410.68 $44,590 - $53,388	-130 Reduced 2.25%	5,650 $2.3 Million
Q3 2023 Oct 31, 2023	SELL	$338.18 - $362.46 $178,559 - $191,378	-528 Reduced 8.37%	5,780 $2.01 Million
Q2 2023 Jul 28, 2023	SELL	$314.42 - $351.91 $503,072 - $563,056	-1,600 Reduced 20.23%	6,308 $2.22 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $33,704 - $38,448	-119 Reduced 1.48%	7,908 $2.49 Million
Q4 2022 Feb 06, 2023	SELL	$285.76 - $321.48 $83,156 - $93,550	-291 Reduced 3.5%	8,027 $2.32 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $26,835 - $29,941	98 Added 1.19%	8,318 $2.41 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $3,994 - $4,973	-17 Reduced 0.21%	8,220 $2.32 Million
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $1.81 Million - $2.13 Million	8,159 Added 10460.26%	8,237 $2.15 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $8,850 - $11,172	50 Added 178.57%	78 $17,000
Q1 2021 Apr 29, 2021	BUY	$207.02 - $241.31 $4,140 - $4,826	20 Added 250.0%	28 $6,000
Q1 2020 Apr 24, 2020	SELL	$199.77 - $247.81 $9,389 - $11,647	-47 Reduced 85.45%	8 $2,000
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $2,500 - $3,358	15 Added 37.5%	55 $12,000
Q3 2019 Nov 01, 2019	SELL	$166.23 - $187.09 $332 - $374	-2 Reduced 4.76%	40 $7,000
Q4 2018 Feb 06, 2019	BUY	$151.91 - $192.21 $4,861 - $6,150	32 Added 320.0%	42 $7,000
Q3 2018 Nov 05, 2018	BUY	$167.73 - $192.74 $1,677 - $1,927	10 New	10 $2,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Account

Alpha Mark Advisors, LLC Vertex Pharmaceuticals Inc Transaction History